ATE169638T1 - Analoge des menschlichen interleukin-8. - Google Patents

Analoge des menschlichen interleukin-8.

Info

Publication number
ATE169638T1
ATE169638T1 AT92924514T AT92924514T ATE169638T1 AT E169638 T1 ATE169638 T1 AT E169638T1 AT 92924514 T AT92924514 T AT 92924514T AT 92924514 T AT92924514 T AT 92924514T AT E169638 T1 ATE169638 T1 AT E169638T1
Authority
AT
Austria
Prior art keywords
pct
analogs
leu5
human interleukin
arg6
Prior art date
Application number
AT92924514T
Other languages
English (en)
Inventor
Ian Clark-Lewis
Bernhard Moser
Original Assignee
Biomedical Res Centre Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomedical Res Centre Ltd filed Critical Biomedical Res Centre Ltd
Application granted granted Critical
Publication of ATE169638T1 publication Critical patent/ATE169638T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/54Interleukins [IL]
    • C07K14/5421IL-8
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/14Lymphokine; related peptides
    • Y10S930/141Interleukin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT92924514T 1991-12-04 1992-12-03 Analoge des menschlichen interleukin-8. ATE169638T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US80157891A 1991-12-04 1991-12-04

Publications (1)

Publication Number Publication Date
ATE169638T1 true ATE169638T1 (de) 1998-08-15

Family

ID=25181500

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92924514T ATE169638T1 (de) 1991-12-04 1992-12-03 Analoge des menschlichen interleukin-8.

Country Status (7)

Country Link
US (1) US5665346A (de)
EP (1) EP0616615B1 (de)
AT (1) ATE169638T1 (de)
AU (1) AU3078892A (de)
CA (1) CA2124461A1 (de)
DE (1) DE69226649D1 (de)
WO (1) WO1993011159A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6258550B1 (en) 1993-04-23 2001-07-10 Virginia Commonwealth University Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site
AU687872B2 (en) 1993-09-14 1998-03-05 Imperial College Of Science, Technology And Medicine Eotaxin: eosinophil chemotactic cytokine
JPH10501700A (ja) * 1994-06-20 1998-02-17 カイロン コーポレイション インターロイキン8レセプター1(il8r1)結合ドメインを有するポリペプチド
US5912232A (en) * 1994-09-23 1999-06-15 Board Of Regents Of The University Of Nebraska Anti-inflammatory polypeptide antagonists of human I1-8
US5627156A (en) * 1994-09-23 1997-05-06 University Of Nebraska Board Of Regents Polypeptide agonists for human interleukin-8
AU3681795A (en) * 1994-09-23 1996-04-09 University Of Nebraska Board Of Regents Polypeptide agonists and antagonists of human interleukin-8
US5656724A (en) * 1994-10-26 1997-08-12 Repligen Corporation Chemokine-like proteins and methods of use
US5789539A (en) * 1994-10-26 1998-08-04 Repligen Corporation Chemokine-like proteins and methods of use
AU6283996A (en) * 1995-06-20 1997-01-22 Chiron Corporation Polypeptides with interleukin-8 receptor binding
US6989435B2 (en) 1997-09-11 2006-01-24 Cambridge University Technical Services Ltd. Compounds and methods to inhibit or augment an inflammatory response
US7067117B1 (en) 1997-09-11 2006-06-27 Cambridge University Technical Services, Ltd. Compounds and methods to inhibit or augment an inflammatory response
US7238711B1 (en) 1999-03-17 2007-07-03 Cambridge University Technical Services Ltd. Compounds and methods to inhibit or augment an inflammatory response
US7091310B2 (en) * 2002-09-13 2006-08-15 Chemokine Therapeutics Corporation Chemokine analogs for the treatment of human disease
US20070116669A1 (en) * 2002-09-13 2007-05-24 Chemokine Therapeutics Corporation Interferon-inducible protein-10 (IP-10 or CXCL10) chemokine analogs for the treatment of human diseases
US20060233748A1 (en) * 2002-09-13 2006-10-19 Ahmed Merzouk Mimetics of interleukin-8 and methods of using them in the prevention, treatment, diagnosis, and ameliorization of symptoms of a disease
EP1363944B1 (de) * 2001-03-01 2006-09-13 University of Saskatchewan Technologies Inc. Hochaffine antagonisten der elr-cxc chemokine
AU2004283910A1 (en) * 2003-10-22 2005-05-06 Laboratoires Serono Sa Novel CXCL8 antagonists
EP1894571A1 (de) * 2006-08-29 2008-03-05 Protaffin Biotechnologie AG Verwendung von modifizierten IL-8 Proteinen zur Behandlung von Reperfusionsschäden und Transplantatabstossung
CN102596227A (zh) * 2009-09-11 2012-07-18 普罗塔芬生物技术股份公司 用于治疗cxcl8介导的肺部炎症的组合物
AU2015397751B2 (en) * 2015-06-03 2019-04-04 Rise Biopharmaceuticals, Inc. (Beijing) Modified chemokine peptide

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5093242A (en) * 1986-10-02 1992-03-03 Massachusetts Institute Of Technology Methods of generating desired amino-terminal residues in proteins
HU205617B (en) * 1987-11-19 1992-05-28 Sandoz Ag Process for producing neturophyl-activating factor, gene coding this and pharmaceutical composition
EP0429542B1 (de) * 1988-08-15 1995-12-06 Brigham And Women's Hospital Leukozyten-adhäsions-inhibitor
EP0504257A4 (en) * 1989-11-29 1993-03-03 Brigham And Women's Hospital (ala il-8) 77 as a leukocyte adhesion inhibitor
AU6747190A (en) * 1989-11-29 1991-06-26 Brigham And Women's Hospital Endothelial-derived il-8
US5079228A (en) * 1990-02-05 1992-01-07 Board Of Regents, The University Of Texas System Peptide inhibitors of neutrophil activating factor induced chemotaxis
IE913192A1 (en) * 1990-09-12 1992-02-25 Scripps Research Inst Active site of interleukin-8: polypeptide analogs and¹antibodies
WO1993001826A1 (en) * 1991-07-19 1993-02-04 East Carolina University Method of treating asthma

Also Published As

Publication number Publication date
DE69226649D1 (de) 1998-09-17
CA2124461A1 (en) 1993-06-10
EP0616615B1 (de) 1998-08-12
US5665346A (en) 1997-09-09
WO1993011159A1 (en) 1993-06-10
EP0616615A1 (de) 1994-09-28
AU3078892A (en) 1993-06-28

Similar Documents

Publication Publication Date Title
ATE169638T1 (de) Analoge des menschlichen interleukin-8.
DE69333023D1 (de) 3-beta-hydroxylierte natürliche Steroidderivate enthaltende Arzneimittelzusammensetzungen und ihre Verwendung
NO952321D0 (no) Polypeptid, samt anti-HIV-preparat fremstilt fra dette
FI960102A0 (fi) Uusi farmaseuttinen seos
DE69326776D1 (de) Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress
HK186596A (en) Pyridine and pyridine n-oxide derivatives of diarylmethyl-piperidines or piperazines compositions and use thereof
DK0760661T3 (da) Farmaceutiske sammensætninger omfattende en opiat-antagonist og calciumsalte, deres anvendelse til behandling af endorfin-m
DK0679092T3 (da) Cytokindæmpende midler
IL112112A0 (en) Peptide derivatives and pharmaceutical compositions containing them
ATE184022T1 (de) Neuropeptide y antagoniste
DK0733046T3 (da) Benzoylguanidiner, deres fremstilling og anvendelse i medikamenter
FI972703A0 (fi) Rekombinantti IL-5-antagonisteja, jotka ovat käyttökelpoisia hoidettaessa IL-5:een liittyviä sairauksia
DK0613499T3 (da) Humame IT-4-mutantproteiner
FI972434A0 (fi) Lamotrigiiniä sisältävä farmaseuttinen koostumus
SE8804628D0 (sv) New compounds
IL98917A0 (en) Piperidyl ethers and thioethers and their use as inhibitors of cholesterol biosynthesis
DK0561846T3 (da) 4,5-dihydroxy- og 4,5,8-trihydroxy-9,10-dihydro-9,10-dioxo-2-anthracencarboxylsyre-dicarbonater og -urethaner med terapeutisk virkning
ATE107853T1 (de) Orales, melatonin enthaltendes arzneimittel.
DK0552205T3 (da) Ny medicinsk anvendelse af et vist indolderivat og farmaceutisk præparat indeholdende dette
ES2108122T3 (es) Composicion a base de amilina o de un analogo de amilina conteniendo opcionalmente insulina, para el tratamiento de la anorexia y de las patologias asociadas.
ATE245998T1 (de) Somatostatin agoniste zur reduzierung von körpergewicht
GB9015774D0 (en) Novel treatment

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties